[go: up one dir, main page]

NO903632D0 - Makrocykliske aminofosfonsyrekomplekser, deres fremstilling, blandinger og anvendelse. - Google Patents

Makrocykliske aminofosfonsyrekomplekser, deres fremstilling, blandinger og anvendelse.

Info

Publication number
NO903632D0
NO903632D0 NO1990903632A NO903632A NO903632D0 NO 903632 D0 NO903632 D0 NO 903632D0 NO 1990903632 A NO1990903632 A NO 1990903632A NO 903632 A NO903632 A NO 903632A NO 903632 D0 NO903632 D0 NO 903632D0
Authority
NO
Norway
Prior art keywords
mixtures
applications
preparation
acid complexes
aminophosphonic acid
Prior art date
Application number
NO1990903632A
Other languages
English (en)
Other versions
NO180434B (no
NO903632L (no
NO180434C (no
Inventor
Jaime Simon
David A Wilson
Joseph R Garlich
David E Troutner
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NO903632D0 publication Critical patent/NO903632D0/no
Publication of NO903632L publication Critical patent/NO903632L/no
Priority to NO964191A priority Critical patent/NO307056B1/no
Publication of NO180434B publication Critical patent/NO180434B/no
Publication of NO180434C publication Critical patent/NO180434C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO903632A 1988-12-19 1990-08-17 Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav NO180434C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO964191A NO307056B1 (no) 1988-12-19 1996-10-03 Fremgangsmåte for rensing av 1,4,7,10-tetraazacyklododekan- 1,4,7,10-tetra(metylenfosfonsyre)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
PCT/US1989/005782 WO1990006776A1 (en) 1988-12-19 1989-12-15 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use

Publications (4)

Publication Number Publication Date
NO903632D0 true NO903632D0 (no) 1990-08-17
NO903632L NO903632L (no) 1990-10-17
NO180434B NO180434B (no) 1997-01-13
NO180434C NO180434C (no) 1997-04-23

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903632A NO180434C (no) 1988-12-19 1990-08-17 Fremgangsmåte for fremstilling av et makrocyklisk aminofosfonsyrekompleks eller et fysiologisk akseptabelt salt derav

Country Status (26)

Country Link
US (1) US5059412A (no)
EP (2) EP0408701B1 (no)
JP (1) JP2515929B2 (no)
KR (1) KR0178966B1 (no)
CN (1) CN1025983C (no)
AR (1) AR248140A1 (no)
AT (1) ATE112689T1 (no)
AU (3) AU639899B2 (no)
BR (1) BR8907255A (no)
CA (1) CA2005880C (no)
CY (1) CY1902A (no)
DE (1) DE68918852T2 (no)
DK (1) DK175479B1 (no)
ES (1) ES2061010T3 (no)
FI (1) FI101857B1 (no)
HK (1) HK146795A (no)
HU (1) HU207454B (no)
IE (2) IE66391B1 (no)
IL (1) IL92784A (no)
MX (1) MX18786A (no)
NO (1) NO180434C (no)
NZ (1) NZ231818A (no)
PT (1) PT92619B (no)
SA (1) SA91120234B1 (no)
WO (1) WO1990006776A1 (no)
ZA (1) ZA899734B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
BR9102490A (pt) * 1990-06-18 1992-01-21 Dow Chemical Co Metodo para uso diagnostico na formacao de imagens e composicao
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
CA2225453C (en) * 1995-06-26 2004-12-14 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
CA2371728C (en) * 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
JP2004536034A (ja) * 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
WO2002055112A2 (en) * 2001-01-09 2002-07-18 Bristol Myers Squibb Co Polypodal chelants for metallopharmaceuticals
WO2003051403A1 (en) * 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
HUE062439T2 (hu) 2013-10-07 2023-11-28 Igl Pharma Inc Eljárás nagy tisztaságú terápiás csont szerek elõállítására
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
WO2016191413A1 (en) 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
KR102395523B1 (ko) 2016-09-27 2022-05-10 바이엘 파마 악티엔게젤샤프트 칼코부트롤의 변형체 a의 결정형의 제조 방법
JP7792746B2 (ja) * 2017-02-08 2025-12-26 アイジーエル ファーマ，インコーポレイティド 治療用骨剤の使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
AU563671B2 (en) * 1984-06-04 1987-07-16 Dow Chemical Company, The Organic amine phosphonic acid complexes
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
AU4700989A (en) 1990-06-21
CN1025983C (zh) 1994-09-28
DE68918852D1 (de) 1994-11-17
SA91120234B1 (ar) 2004-09-04
AU4828290A (en) 1990-07-10
DK175479B1 (da) 2004-11-08
EP0408701A4 (en) 1991-07-31
KR0178966B1 (ko) 1999-03-20
PT92619A (pt) 1990-06-29
CY1902A (en) 1989-12-15
DE68918852T2 (de) 1995-05-11
FI101857B (fi) 1998-09-15
ES2061010T3 (es) 1994-12-01
JP2515929B2 (ja) 1996-07-10
HU901163D0 (en) 1991-03-28
NO180434B (no) 1997-01-13
EP0408701A1 (en) 1991-01-23
CA2005880A1 (en) 1990-06-19
JPH03502936A (ja) 1991-07-04
FI904084A0 (fi) 1990-08-17
NO903632L (no) 1990-10-17
BR8907255A (pt) 1991-03-12
WO1990006776A1 (en) 1990-06-28
KR910700073A (ko) 1991-03-13
EP0375376A2 (en) 1990-06-27
IL92784A (en) 1994-08-26
IE66391B1 (en) 1995-12-27
EP0408701B1 (en) 1994-10-12
HU207454B (en) 1993-04-28
HUT54897A (en) 1991-04-29
AU5068593A (en) 1994-02-24
NO180434C (no) 1997-04-23
IE940833L (en) 1990-06-19
DK195990D0 (da) 1990-08-16
MX18786A (es) 1993-12-01
FI101857B1 (fi) 1998-09-15
IL92784A0 (en) 1990-09-17
CA2005880C (en) 1999-01-05
US5059412A (en) 1991-10-22
AR248140A1 (es) 1995-06-30
NZ231818A (en) 1992-05-26
HK146795A (en) 1995-09-22
ZA899734B (en) 1991-08-28
IE894063L (en) 1990-06-19
CN1046739A (zh) 1990-11-07
EP0375376A3 (en) 1991-06-12
AU639899B2 (en) 1993-08-12
AU657641B2 (en) 1995-03-16
DK195990A (da) 1990-08-16
ATE112689T1 (de) 1994-10-15
PT92619B (pt) 1995-09-12

Similar Documents

Publication Publication Date Title
NO903632L (no) Makrocykliske aminofosfonsyrekomplekser, deres fremstilling, blandinger og anvendelse.
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
DK158659C (da) 2,4,6-triiod-isophthalsyrederivater, deres fremstilling og roentgenkontrastmidler indeholdende disse.
FI881057A0 (fi) I dubbelhjul gripande flyttanordning.
FI902165A0 (fi) Selektivt fungerande taendare.
IT8820074A0 (it) Complessi di platino (ii), loro preparazione e impiego come antitumorali.
NO900469L (no) Piperidinforbindelser, deres fremstilling og anvendelse.
DE68921285D1 (de) Permutationsschloss.
DK462187D0 (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO892808D0 (no) (aza)naftalensultam-derivater og deres fremstilling.
FI892186L (fi) Foerfarande foer att laosa laosorganen i spontvaeggar.
FI893518L (fi) Selektivt 0-acylerade glykosaminoglykaner.
NO891749L (no) Syreaddisjonssalter, deres fremstilling og anvendelse.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
FI894648A0 (fi) Kemiska foereningar.
DE68912416D1 (de) Spielzeug.
NO903978D0 (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
FI890691A0 (fi) Makroporoesa selektiva jonbytarhartser.
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
FI890896A0 (fi) Extremt flexibel polypropenfiber.
DE3873749D1 (de) Vielpoliger steckbverbinder.
NO892570L (no) Polysilazaner, deres fremstilling og anvendelse.
NO911243D0 (no) Kjemiske preparater.
DE3875835D1 (de) Antivirale, antitumoraktive und fungizide zusammensetzungen.
NO894505D0 (no) Vandig cisplatinloesning.

Legal Events

Date Code Title Description
MK1K Patent expired